Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma

NCT00185861 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Brain Cancer

Interventions

DRUG: Arsenic Trioxide
PROCEDURE: Stereotactic radiosurgery

Sponsor

Stanford University

Collaborators

[object Object]
[object Object]